Literature DB >> 10360588

Inhibition of human dendritic cell functions by methylprednisolone.

N Vanderheyde1, V Verhasselt, M Goldman, F Willems.   

Abstract

BACKGROUND: The aim of this study was to better define how glucocorticoids influence primary human T cell responses. Dendritic cells (DC*) are the most effective antigen presenting cells able to activate naive T cells. Previous studies have shown that dexamethasone impaired the function of murine DC. Here, we analyzed how methylprednisolone (MP) might affect the function and maturation of human DC.
METHODS: Human DC were generated from peripheral blood mononuclear cells cultured in granulocyte macrophage-colony stimulating factor and interleukin (IL)4. DC maturation was induced either by lipopolysaccharide (LPS) or by fibroblast transfected with the CD40-ligand gene (3T6-CD40L). DC phenotype was characterized by flow cytometric analysis, their cytokine production by ELISA. The ability of DC to activate naive T cells was evaluated in mixed leukocyte reactivity.
RESULTS: Although MP did not affect viability of DC, it enhanced their antigen uptake and down-regulated their basal expression of CD86. The expression of CD80 and CD54 by DC was slightly decreased and HLA-DR expression was not modified. MP prevented LPS-induced DC maturation as assessed by the inhibition of CD86, CD80 and CD54 up-regulation, CD83 induction and production of TNF-alpha, IL-6, and IL-12. In contrast, when DC were stimulated by 3T6-CD40L, MP prevented only the synthesis of IL-12. Moreover, MP-treated DC were deficient in their ability to elicit proliferative responses of CD4+CD45RA+ allogeneic T cells as well as their synthesis of interferon (IFN)-gamma, IL-5, and IL-13. CONCLUSION. Glucocorticoids exert potent suppressive effects on human DC and thereby inhibit the induction of primary T cell responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360588     DOI: 10.1097/00007890-199905270-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

1.  The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies.

Authors:  Mahmoud R Hussein; Sherifa A Hamed; Mohammed G Mostafa; Eman E Abu-Dief; Nageh Fouly Kamel; Mahmoud R Kandil
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

2.  Impairment of circulating myeloid dendritic cells in immunosuppressed liver transplant recipients.

Authors:  B M Bosma; H J Metselaar; W M W Tra; S Mancham; E J Kuipers; H W Tilanus; J Kwekkeboom
Journal:  Clin Exp Immunol       Date:  2007-07-23       Impact factor: 4.330

3.  Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

4.  Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC.

Authors:  Bartosz Bielecki; Andzelika Mazurek; Paweł Wolinski; Andrzej Glabinski
Journal:  J Clin Immunol       Date:  2007-10-25       Impact factor: 8.317

5.  Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells.

Authors:  Brenda M Bosma; Herold J Metselaar; Nicole M A Nagtzaam; Roel de Haan; Shanta Mancham; Luc J W van der Laan; Ernst J Kuipers; Jaap Kwekkeboom
Journal:  Immunology       Date:  2008-02-27       Impact factor: 7.397

6.  Production of antineutrophil cytoplasm antibodies derived from circulating B cells in patients with systemic vasculitis.

Authors:  A R Clayton; C O S Savage
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

7.  Monocyte implication in renal allograft dysfunction.

Authors:  E Guillén-Gómez; L Guirado; X Belmonte; A Maderuelo; S Santín; C Juarez; E Ars; C Facundo; J A Ballarín; S Vidal; M M Díaz-Encarnación
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

8.  Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.

Authors:  Sarah L Jongbloed; M Cristina Lebre; Alasdair R Fraser; J Alastair Gracie; Roger D Sturrock; Paul P Tak; Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Cell therapy using tolerogenic dendritic cells in transplantation.

Authors:  Aurélie Moreau; Emilie Varey; Laurence Bouchet-Delbos; Maria-Cristina Cuturi
Journal:  Transplant Res       Date:  2012-09-28

Review 10.  Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation.

Authors:  Giuseppe Vassalli
Journal:  J Transplant       Date:  2013-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.